Basel, 26 May 2016

We are pleased to invite you to an analyst briefing to discuss data presented on the Roche Group's oncology products and pipeline at the American Society of Clinical Oncology Annual Meeting (ASCO) in Chicago (3 - 7 June 2016).

Meeting information

Date: 5 June 2016
Time (CDT):
6:00pm Registration desk opens
6:30pm Start of meeting
8:00pm End of meeting followed by a buffet reception
Download to my calender (download to your calendar will be in local time Chicago)

Venue

Marriott Downtown Chicago
Chicago E-H (Level 5)
540 North Michigan Avenue
60611 Chicago
map

Agenda

  • Oncology strategy and outlook
    Daniel O'Day, Chief Operating Officer Roche Pharmaceuticals
  • Early pipeline update: assets and strategies
    Ira Mellman, gRED: Ph.D., Vice President, Cancer Immunology, Genentech
    William Pao, pRED: M.D., Ph.D., Global Head Oncology Discovery and Translational Area, Roche
  • Roche highlights in cancer immunotherapy
    Daniel S. Chen, M.D. Cancer immunotherapy Franchise Head Product Development, Genentech/Roche
  • Targeted therapies and future combinations
    Sandra Horning, M.D., Chief Medical Officer and Head Global Product Development

To register for the event, please follow the link (Password: Analyst2016).

Dial in to the conference 10-15 minutes prior to the scheduled start, using the following dial-in numbers (listen-only mode, no live-access to speakers):
+41 (0) 58 310 5000 (Europe and ROW) or
+44 (0) 203 059 5862 (UK) or
+1 (1) 631 570 5613 (USA)

To expedite the registration process on the day of the conference call, you may pre-register for the event. click here

Alternatively a live audio webcast can be accessed via http://ir.roche.com.
The presentation slides will be available from the IR website at http://ir.roche.com following to the closure of the ASCO meeting.

A replay of the webcast will be available on demand on the Roche website. click here.

In addition, we have prepared an ASCO planner providing an overview of oral and poster abstracts relevant to Roche, including indication of time and venue of the respective presentations at the congress. This planner can be downloaded here.

Roche Holding AG published this content on 26 May 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 26 May 2016 12:10:02 UTC.

Original documenthttp://www.roche.com/investors/updates/inv-update-2016-05-26.htm

Public permalinkhttp://www.publicnow.com/view/5185C2651E20D7FCB0DA1F6891DA96532313F1A6